Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  N NERVOUS SYSTEM
    N02 ANALGESICS
      N02C ANTIMIGRAINE PREPARATIONS
        N02CD Calcitonin gene-related peptide (CGRP) antagonists
          N02CD03 Fremanezumab
            D11055  Fremanezumab (USAN/INN) <JP/US>

USP drug classification [BR:br08302]
  Antimigraine Agents
    Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist
      Fremanezumab
        D11055  Fremanezumab (USAN/INN)

Therapeutic category of drugs in Japan [BR:br08301]
  1  Agents affecting nervous system and sensory organs
    11  Agents affecting central nervous system
      119  Miscellaneous
        1190  Miscellaneous
          D11055  Fremanezumab (USAN/INN); Fremanezumab (genetical recombination) (JAN)

Target-based classification of drugs [BR:br08310]
  Not elsewhere classified
    Organismal systems
      Circulatory system
        CALCA (CGRP) [HSA:796] [KO:K12332]
          D11055  Fremanezumab (USAN/INN) <JP/US>

New drug approvals in the USA [br08319.html]
  D11055

New drug approvals in Europe [br08329.html]
  D11055

New drug approvals in Japan [br08318.html]
  D11055

New drug approvals in the USA, Europe and Japan [br08328.html]
  D11055